Introduction {#S1}
============

Along with sensory, thermoregulatory and barrier functions, the skin contains a large repertoire of innate and adaptive immune cells that are responsible for the defense against environmental and microbial insults. The epidermis harbors Langerhans cells (LC) and, in the mouse, dendritic epidermal T cells (DETC). In the dermis, macrophages, dermal dendritic cells (DDC), mast cells, T cells and other immune cell populations reside in a fibroblast-rich network of collagen and elastin.

Given that the dermis is a structurally non-homogeneous tissue that contains a large variety of immune cells, it is likely that certain functional leukocyte subsets localize to specific anatomical niches. Support of such cellular and anatomical niches was recently reported, where two distinct fibroblast lineages were found to give rise to the upper dermis, responsible for the dermal papilla and hair follicle formation, and to the lower dermis in murine skin ([@R7]). As yet, immune cell composition changes with depth, from the dermo-epidermal junction (DEJ) through to the subcutaneous fat, and its relationship to other anatomical structures, such as the vasculature, has received little attention. Moreover, several novel dermal immune cell subsets (reviewed in [@R43]) such as DDC (reviewed in [@R17]), dermal type 2 innate lymphoid cells (dILC2) ([@R32]) and dermal γδ T cells ([@R40]) have only been described very recently, and their precise localization is not entirely clear.

While the underlying pathomechanisms for the propensity for inflammatory skin diseases to occur at specific predilection sites remain unknown, infection studies suggest intrinsic differences in the skin immune system between different sites. Murine skin infections with *Leishmania major*, for example, lead to functionally divergent outcomes depending upon the site of challenge ([@R26]; [@R27]; [@R2]; [@R42]). Although not studied systematically, anecdotal evidence suggests that topographical variations in immune cell densities exist for different body sites ([@R5]). Mapping cutaneous immune cell compositions topographically therefore has implications for interpreting the context of immune responses during infections and autoimmune diseases.

Central to such investigations is the ability to accurately quantify the numbers and positioning of the relevant immune subpopulations. While traditional histology and flow cytometric approaches have provided fundamental understanding of the skin immune system, each has certain drawbacks ([@R9]). Tissue processing poses risks of introducing artifacts, for example shrinkage, thereby confounding analysis of anatomical relationships, and also potentially masking epitopes necessary for the proper identification of immune subpopulations by antibodies. Multi-parametric flow cytometry allows for the accurate identification and enumeration of even scarce immune cell subsets, however provides no spatial information whilst 3D tissue reconstruction based on serial sections can be limited in scope.

In more recent years, the use of multiphoton microscopy (MPM), in conjunction with fluorescent reporter mice, has enabled the direct and 3D visualization of tagged leukocyte subpopulations within intact skin ([@R19]; [@R16]). The use of near infrared laser light in MPM allows for deep tissue imaging with minimal photobleaching and phototoxicity. In addition, the extracellular matrix (ECM) can be visualized based on second harmonic generation (SHG) signals, thereby providing structural information. Nevertheless, as for other microscopy approaches, MPM relies on cell-specific fluorescent tags within transgenic reporter mice. Since transgene expression is seldom restricted to a single immune subpopulation, the accurate enumeration of fluorescent cells requires the combination of MPM with flow cytometry.

Here, we describe the combinatorial approach of incorporating both MPM and flow cytometry to quantify the major leukocyte populations within the epidermis and dermis. We further demonstrate the utility of this method by comparing immune composition between different sites and animal age. This "Immune Atlas" provides a platform for the interpretation of site-specific immunity with implications for the understanding of skin physiology, immunopathology and the actions of therapeutics.

Results {#S2}
=======

MPM enables the faithful reconstruction of structurally heterogeneous skin sites *in situ* {#S3}
------------------------------------------------------------------------------------------

Structural differences in human skin from different sites have been described at the microscopic and ultrastructural level ([@R23]). Topographical variation in murine skin is less well documented. We focused our study on the mouse ear pinnae, dorsal back, footpad and tail skin, as representative sites of experimental immunological investigations. Structural differences observed in histological sections from H&E ([Supplementary Figure 1a--d](#SD2){ref-type="supplementary-material"}, *left column*) and Milligan's trichrome stain ([Supplementary Figure 1a--d](#SD2){ref-type="supplementary-material"}, *middle column*) from these sites were detectable with MPM including the thin epidermis and dermis of ear skin ([Supplementary Figure 1a](#SD2){ref-type="supplementary-material"}); the thicker epidermis, dermis and subcutis of back skin ([Supplementary Figure 1b](#SD2){ref-type="supplementary-material"}); the lack of hair follicles in footpads, akin to glabrous skin in humans ([Supplementary Figure 1c](#SD2){ref-type="supplementary-material"}); and the thick stratum corneum of footpad and tail skin ([Supplementary Figure 1c--d](#SD2){ref-type="supplementary-material"}). Confirmation of these structural features with MPM was possible through the imaging of intact skin from transgenic mT/mG mice ([@R25]), in which all cells express cell-membrane-localized red fluorescence ([Supplementary Figure 1a--d](#SD2){ref-type="supplementary-material"}, *right column*). We further visualized ECM fibers through SHG signals, thereby delineating dermal tissue ([Supplementary Figure 1a--d](#SD2){ref-type="supplementary-material"}, *right column*). Thus, with MPM, we can detect structural features such as epidermal thickness and topography of the DEJ *in situ* without tissue processing or counter-staining to generate 3D tissue stacks of intact murine skin.

Microanatomical specialization of dermal leukocytes at depth and between sites {#S4}
------------------------------------------------------------------------------

The spatial distribution of dermal macrophages ([@R49]), mast cells ([@R14]; [@R48]) and T cells ([@R6]) has been extensively studied in human skin. Whether similar densities and distributions of leukocytes are also found in mouse skin is not known, and potentially important given the extensive use of mouse models to study skin diseases. A prerequisite for accurately assessing and quantifying defined, fluorescently-tagged target cell populations in the epidermis and dermis is that fluorescence expression is sufficiently bright to be visualized when analyzing the full thickness of skin by MPM, and that the epidermis and dermis were distinguishable from each other. This led us to select *Cxcr6*^+/gfp^ mice, in which T cell subsets and dILC2 cells express GFP ([@R40]; [@R32]), and *Csf1r*-EGFP (designated hereafter as MacGreen) mice, in which all myeloid cells express GFP ([@R34]). In *Cxcr6*^+/gfp^ mice, CD3^−^CD2^+^ NK cells also express GFP however are rarely found in the skin under homeostatic conditions ([@R32]). No other ILC subsets were observed in the skin during steady state, as confirmed by others ([@R39]).

Both LC and DETC could be visualized in the epidermis (as defined by the absence of SHG signals ([@R29])) of MacGreen and *Cxcr6*^+/gfp^ mice, respectively ([Figure 1a](#F1){ref-type="fig"}, *Epidermis*). Further, GFP^+^ cells in both MacGreen and *Cxcr6*^+/gfp^ mice could be readily visualized in the dermis ([Figure 1a](#F1){ref-type="fig"}). While GFP^+^ lymphocytes in *Cxcr6*^+/gfp^ mice were not found at depths greater than 100μm from the DEJ, myeloid cells including macrophages in MacGreen mice were visible much deeper (up to the cartilage in the ear, [Figure 1a](#F1){ref-type="fig"}, arrowheads, and up to 240μm at other sites, data not shown). Since the GFP fluorescence expression of cells in *Cxcr6*^+/gfp^ mice was comparatively higher than in MacGreen mice as shown by flow cytometry (1.4 to 2.9 fold, [Supplementary Figure 2a](#SD2){ref-type="supplementary-material"}), we concluded that MPM was sufficient for the detection of deep dermal immune cells.

For accurate enumeration of immune cells by flow cytometry, enzymatic separation of the epidermis and dermis was required ([@R45]). One potential confounding factor with this approach may be their incomplete separation resulting in contamination of either compartment. We first tested efficient separation of the epidermis and dermis by dispase treatment with confocal microscopy ([Supplementary Figure 2b](#SD2){ref-type="supplementary-material"}), and found that while the epidermal sheet was effectively removed, pockets of epidermal cells from the hair follicles remained within the dermis. To assess the potential impact of this epidermal component on leukocyte quantification, we enumerated GFP^+^ DETC and LC present within hair follicles in *Cxcr6*^+/gfp^ ([@R40]) and MacGreen ([@R31]) mice by MPM, respectively. We observed that 1--2% of DETC and 1--3% of LC cells reside within hair follicles when compared to those resident in the interfollicular epidermis ([Supplementary Figure 2c--d](#SD2){ref-type="supplementary-material"}). Flow cytometric identification of CD326^hi^ LC and CD3^hi^ DETC in both the epidermal and dermal leukocyte preparations following dispase treatment ([Supplementary Figure 2e](#SD2){ref-type="supplementary-material"}) confirmed minimal contamination of the dermal leukocyte preparation with epidermal-derived DETC and LC (less than 1% of total CD45^+^ cells), consistent with the MPM data.

Our combinatorial approach of MPM imaging and flow cytometry was employed to enumerate immune cell subsets in the skin. To this end, 3D tissue stacks were obtained by MPM from intact ear, back, footpad and tail skin in a variety of transgenic reporter mice, and fluorescent cells enumerated post acquisition using image analysis software. We used CD11c-YFP, c-Kit-eGFP, *Cxcr6*^+/gfp^ and DPE-GFP mice to determine the spatial distribution of dermal dendritic cells (DDC), mast cells, dermal T cells and macrophages, respectively ([Figure 1b](#F1){ref-type="fig"}). These mouse strains had been used previously to determine the phenotype, relative proportions and localization of the respective leukocyte subsets ([@R29]; [@R31]; [@R40]; [@R32]; [@R1]). The DPE-GFP mouse, driven by the *Cd4* enhancers and promoter ([@R22]), also demonstrate GFP expression in αβ T cells and plasmacytoid dendritic cells ([@R15]), however the former can be easily distinguished from the dendritic-like morphology of macrophages as opposed to the rarer amoeboid T cells (see [Figure 1a](#F1){ref-type="fig"}, *Superficial Dermis*) whilst the latter are not found in the skin under homeostatic conditions ([Supplementary Figure 3a](#SD2){ref-type="supplementary-material"}). Furthermore, GFP^+^ macrophages in the skin of DPE-GFP mice ([@R1]) express GFP at a markedly higher level than skin-resident αβ T cells ([Supplementary Figure 3b](#SD2){ref-type="supplementary-material"}). Therefore, only dendritic-like GFP^hi^ cells were enumerated in these mice to quantify macrophages. For the visualization of mast cells, the c-Kit-eGFP mice were specifically used because the GFP expression reported mast cell *Kit* expression ([Supplementary Figure 3c](#SD2){ref-type="supplementary-material"}), and not other Kit-expressing cells. Thus, hematopoietic stem cells do not express GFP in these mice, and melanocytes express GFP at two orders of magnitude less than mast cells ([@R4]). Quantification of the relative percentages of immune cell subsets as determined by flow cytometry was used to adjust numbers obtained by MPM (see Materials and Methods and [Supplementary Table 1](#SD2){ref-type="supplementary-material"}). This combinatorial approach allowed us to calculate the actual density of specific cell subsets per tissue unit (mm^3^) stratified at depth.

Our image analyses revealed non-uniform distributions of leukocyte subsets in the vertical direction ([Figure 1b](#F1){ref-type="fig"}). DDC and dermal T cells resided preferentially within the superficial dermis, whilst macrophages were also found in the deeper regions of the dermis. Mast cells in the ear localized mainly to the superficial dermis, while at other sites they were found at similar densities throughout the dermis. Relative proportions of individual leukocyte subsets varied with depth, and these variations differed between sites.

We then compared the densities of LC (MacGreen mice; [Figure 2a](#F2){ref-type="fig"}), CD64^−^MHC-II^hi^ DDC (CD11c-YFP mice; [Figure 2b](#F2){ref-type="fig"}), mast cells (c-Kit-eGFP mice; [Figure 2c](#F2){ref-type="fig"}), DETC (*Cxcr6*^+/gfp^ mice; [Figure 2d](#F2){ref-type="fig"}), CD3^int^ T cells (*Cxcr6*^+/gfp^ mice; [Figure 2e](#F2){ref-type="fig"}) and CD64^+^ macrophages (DPE-GFP mice; [Figure 2f](#F2){ref-type="fig"}) using the combinatorial approach. In order to avoid confounding effects of varying epidermal thickness between sites ([Supplementary Figure 1](#SD2){ref-type="supplementary-material"}), LC and DETC density was reported per mm^2^ (leukocyte number underlying a mm^2^ of skin surface boundary at any depth). Dermal leukocytes density is shown per mm^3^ (and per mm^2^ in [Supplementary Table 2](#SD2){ref-type="supplementary-material"}, which were comparable to volumetric measurements). We found that mast cells were most prevalent in ear skin, while DETC and dermal T cells were most prevalent in back skin compared to other sites. Higher densities of dermal macrophages were found in ear skin and footpads compared to back skin, whereas DDC were homogeneous in their distribution, with no site-specific differences observed. LC were similarly homogeneous in their distribution except for tail skin, where densities were less than half compared to other sites. Total leukocyte numbers in the epidermis (LC and DETC) and dermis (DDC, mast cells, T cells and macrophages) were calculated ([Figure 2g](#F2){ref-type="fig"}). The relative site-specific contributions of dermal leukocyte subsets were highly variable, although DDC and macrophages consistently comprise the majority of dermal leukocytes ([Figure 2h](#F2){ref-type="fig"}).

Quantitative differences in T cell subsets in ear skin of young and older mice {#S5}
------------------------------------------------------------------------------

Given the precision of this approach in quantifying immune cells within the skin, particularly the dermis, we next examined the T cell composition within the ear in young and old mice. Ageing reportedly impacts the composition of immune cells, particularly in the adaptive arm, in a variety of organs including skin (reviewed in [@R41]; [@R46]). We made use of *Cxcr6*^+/gfp^ mice, and extended our analysis to GFP^+^ dermal αβ T cells, γδ T cells and dILC2 cells ([@R40]; [@R32]). MPM was performed *in situ* in 8--12 week and \>12 months old mice as shown in [Figure 3a](#F3){ref-type="fig"}. We observed an increased number of GFP^+^ cells in the dermis of mice \> 12 months old and employed flow cytometric analysis to determine the composition of dermal lymphocytes by delineating CD90^hi^ leukocytes into dermal αβ T cells, γδ T cells and dILC2 cell subsets ([Supplementary Figure 3d](#SD2){ref-type="supplementary-material"}). Combinatorial MPM and flow cytometry analyses revealed that dermal αβ T cells were significantly increased, while dILC2 cells remained largely unaffected by age. Interestingly, and unexpectedly, γδ T cells were also increased in older mice ([Figure 3b](#F3){ref-type="fig"}). The change in αβ T cells may be explained by the fact that T cells in aged mice, similar to humans, display a shift from naïve to memory phenotype during ageing (reviewed in [@R10]).

Quantitative analysis of cell distances to blood vessels demonstrate differences between dermal populations in murine ears *in vivo* {#S6}
------------------------------------------------------------------------------------------------------------------------------------

The localization of some immune cell subsets in close proximity to blood vessels has been described on tissue sections ([@R8]). In order to quantify the 3D relationship between leukocytes and the vasculature *in vivo*, we developed an image analysis algorithm to automate the measurement of distances of leukocytes to blood vessels in the ear of mice under live imaging conditions (see [Supplementary Materials and Methods](#SD1){ref-type="supplementary-material"}; freely available at <http://www.matebiro.com/software/immuneatlas>). We included mast cells, which are largely non-migratory ([Figure 4a](#F4){ref-type="fig"}, *top row*), and DDC, which show constitutive migration within non-inflamed dermis ([@R29]) ([Figure 4a](#F4){ref-type="fig"}, *bottom row*). We found that 54.2% and 36.4% of mast cells and DDC, respectively, resided within 10 μm of the nearest blood vessel ([Figure 4b](#F4){ref-type="fig"}). Overall, differences in cell to blood vessel distances for mast cells and DDC were highly significant ([Figure 4c](#F4){ref-type="fig"}), confirming the non-homogeneous distribution of individual leukocyte subsets in the dermis by live imaging *in vivo*.

Site-specific differences in mast cell numbers associate with functionally distinct immune responses {#S7}
----------------------------------------------------------------------------------------------------

Finally, we set out to determine whether variations in densities of leukocyte subsets paralleled differences in immune reactions between these sites. We focused on mast cells, based upon clear disparity in densities between ear and back skin by MPM ([Figure 2c](#F2){ref-type="fig"} and [5a](#F5){ref-type="fig"}), and confirmed by toluidine blue staining on histological sections ([Figure 5a](#F5){ref-type="fig"}) ([@R13]). Mast cells contribute to allergic responses through IgE-mediated release of preformed mediators such as histamine -- a potent mediator of vascular permeability (reviewed in [@R11]). Therefore, we employed the passive cutaneous anaphylaxis model ([@R50]), a test for mast cell function *in vivo*. Antigen-specific IgE was injected intradermally in the ear and dorsal back in albino C57BL/6-*Tyr^c-2J^*/J mice. The antigen and Evans blue dye was injected *i.v.* 16 h later resulting in histamine release, vascular leakage and dye extravasation ([Figure 5b](#F5){ref-type="fig"}). Mast cell-deficient C57BL/6J-*Kit*^W-sh/W-sh^ mice were used as a negative control ([Figure 5b](#F5){ref-type="fig"}). We observed increased dye extravasation in the ear compared to the back ([Figure 5c](#F5){ref-type="fig"}), consistent with the higher numbers of mast cells in ear skin. This difference was not seen in vehicle controls or in C57BL/6J-*Kit*^W-sh/W-sh^ mice ([Figure 5b](#F5){ref-type="fig"}), confirming that Evans blue leakage was mast cell-dependent. Thus, there is a functional correlation between the density of mast cells and dye leakage after experimental passive cutaneous anaphylaxis.

Discussion {#S8}
==========

The mechanisms underlying regional immunity, that is differences in the quality of immune responses between different organs such as the gut and the skin, are increasingly recognized ([@R35]). We now appreciate that within a given organ, immune cell populations can be heterogeneous in composition. The skin is a good example in this context, and has served as a widely used paradigm to study regional immunity and the specialized functions of leukocyte subsets. Our results suggest layers of complexity to the immune microcosm in the skin, namely site-specific differences in immune cell density. Furthermore, the differences seen in mast cell density suggest cutaneous immune responses indeed may display site-specific functional reactivity. This complexity also extends to the non-homogeneous arrangement and relative proportions of distinct populations of immune cells based on tissue depth, which may have implications for the ensuing immune response upon pathogen entry into the skin.

Our intravital imaging approach represents a methodological advance, as it circumvents technical challenges of conventional histologic approaches, such as sample shrinkage and tissue processing artifacts. In combination with multi-parameter flow cytometry, MPM enabled quantification of densities of several leukocyte subsets in the skin at different depths (up to 240 μm from the DEJ) including the epidermis. We found that the spatial distribution of dermal leukocytes was significantly region-specific. However similarities between sites included DDC and T cells residing in the superficial dermis whilst macrophages and mast cells were generally distributed throughout the entire dermis. Our data confirm the spatial distribution of human dermal macrophages ([@R49]) and mast cells ([@R14]; [@R48]). We consistently found accumulation of T cells directly underneath the murine epidermis, which in contrast to human studies, are reported to distribute throughout the dermis ([@R6]). We further corroborate the close association of mast cells, in contrast to DDC, to blood vessels. Finally, the combinatorial approach employed in this study quantified individual T cell subsets and revealed that γδ T cells are numerically increased in the skin of aged mice. Until recently, γδ T cells were thought to be a purely innate immune population. However, recent studies indicate they are capable of exhibiting hallmarks of memory, as demonstrated in the intestine after *Listeria monocytogenes* infection ([@R38]) and in the peritoneal cavity after *Staphylococcus aureus* infection ([@R24]). Our results raise the intriguing possibility that dermal γδ T cells, which represent a distinct but nevertheless polyclonal γδ T cell population ([@R40]), may also be capable of exhibiting memory. Collectively, our results demonstrate the suitability of our combinatorial approach to the quantification of numerous immune cell subpopulations within the skin across a range of sites and experimental conditions.

Recently, Wang *et al*. (2014) employed 3D microscopy in human skin using whole-mount immunofluorescence staining of dendritic cells, macrophages and T cells. They demonstrated distinct microanatomical localization of these cells depending on tissue depth. Whilst their study used skin harvested from breast reduction surgery and quantified up to a depth of 60 μm as well as greater than 150 μm from the DEJ, their data was consistent with our results in murine skin. Nevertheless, they describe cord-like perivascular distribution of dermal leukocytes past a depth of 150 μm from the DEJ. Although we occasionally see T cells and mast cells in footpad skin *in situ* arranged in a perivascular fashion in the deep dermis, this is rather an exception. It remains to be confirmed whether these observed differences relate to different techniques employed to highlight leukocytes, sample processing of human tissue or true species differences. In the future, our customized image analysis package can be applied to whole human skin similarly stained, but 'optically cleared' (reviewed in [@R51]) to ensure that no cell escapes detection.

Despite the strengths of the described combinatorial approach, criteria must be met in order for it to be employed effectively. The depth of microscopic examination and therefore tissue thickness affects the ability for fluorescence to be detected. These factors may change in physiological (e.g. different body sites) as well as pathological states (e.g. inflammation). To be confident of quantification, the entire dermis needs to be visualized and thus may not be applicable in skin with severe inflammation or excessive epidermal thickening. Despite remaining challenges, our method has potential applications for developmental studies (e.g. using knockout mice) and a range of experimental conditions, where sensitive and accurate immune cell quantification is required.

Further, completing the skin "Immune Atlas" will require comprehensive topographical and spatial detailing of lymphatics and nerves ([@R45]) and their association with dermal leukocytes. Potential approaches include labelling of these structures *in vivo* for simultaneous visualization with leukocytes ([@R18]). Although *in vivo* examination of human skin is still in its infancy, exploiting inherent physical properties of tissue through second and third harmonic generation signals may allow a human atlas of skin to be developed ([@R33]; [@R44]). The systematic combinatorial approach we describe would enable confirmation of earlier studies documenting the effect of ultraviolet radiation on regional variation in leukocyte density ([@R3]). Applications include evaluating the skin microbiome, known to be topographically diverse and to extend below the DEJ ([@R28]), and its possible influence on leukocyte diversity in the epidermis and dermis. This may have therapeutic implications when microflora are altered in the setting of certain inflammatory skin disorders (reviewed in [@R12]; [@R36]).

In summary, we describe a robust and versatile quantification technique to investigate the immune system of the skin by incorporating multiphoton imaging data and correcting for non-uniform fluorescence expression in transgenic reporter mice with multi-parameter flow cytometry. The result is the comprehensive mapping of the skin immune system in 3D, accessible to investigators for dissecting the immune response in skin for better understanding of physiological and pathological changes during infection and autoimmunity.

Materials and Methods {#S9}
=====================

Mice {#S10}
----

C57BL/6 mice were obtained from the Animal Research Centre in Perth, Australia. Albino C57BL/6 (B6(Cg)-*Tyr^c-2J^*/J), *Cxcr6*^+/gfp^, and mT/mG mice ([@R25]) were purchased from the Jackson Laboratory. CD11c-YFP mice ([@R20]) were a gift from M. Nussenzweig. The c-Kit-eGFP mice ([@R4]) were a gift from P. Besner. The *Csf1r*-EGFP (MacGreen) mice ([@R34]) were a gift from D. Hume. DPE-GFP mice have been described previously ([@R22]). Mice were bred and maintained on the C57BL/6 background in pathogen-free conditions at the Centenary Institute animal facility. *Kit*^W-sh/W-sh^ ([@R13]) backcrossed 14 generations to C57BL/6J mice and also albino C57BL/6(Cg)-*Tyr^c-2J^*/J were bred and maintained at the Institute of Medical and Veterinary Science animal facility, Adelaide. All experiments performed were approved by the Animal Ethics Committees at the University of Sydney (Sydney, Australia), Royal Prince Alfred Hospital (Sydney, Australia) and the Institute of Medical and Veterinary Science Animal Ethics Committee (Adelaide, Australia).

Multiphoton imaging {#S11}
-------------------

A combination of *ex vivo* and *in vivo* imaging of murine skin were performed. For *in vivo* imaging, mice were anesthetized with Ketamine/Xylazine (80/10mg/kg, i.p.) with repeated half-doses as required. The anesthetized mouse was mounted on a custom-built ear stage with its body temperature controlled as described previously ([@R29]; [@R19]). MPM was performed on a custom-built TriMScope (LaVision BioTec, Bielefeld, Germany) attached to an Olympus BX-51 fixed stage microscope equipped with either a 16× (Nikon LWD, NA 0.80; Nikon, Tokyo, Japan) or 20× (Olympus XLUMPlanFl IR coated, numerical aperture (NA) 0.95; Olympus, Center Valley, PA) water immersion objective. For *ex vivo* imaging, mice were euthanized using CO~2~ asphyxiation, hair removed with Nair, and tissue harvested from the ear, dorsal back, footpad and tail skin. A wideband mode-locked Ti:sapphire femtosecond laser (Mai Tai HP/Spectra-Physics; Newport Corporation, Irvine, CA) was used to excite the skin at a wavelength of 920 nm or 940 nm for imaging of GFP and YFP respectively. Blood vessels were visualized through *i.v*. (tail vein) injection of Evans blue (Gurr-Searle Diagnostic) conjugated to BSA ([@R1]).

The combinatorial approach using MPM and flow cytometry for enumeration of actual epidermal and dermal leukocyte densities in transgenic fluorescent mice *in situ* {#S12}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------

Image stacks were acquired from MacGreen, CD11c-YFP, c-Kit-eGFP, DPE-GFP and *Cxcr6*^+/gfp^ mice to enumerate LC, DDC, mast cells, macrophages, and lymphoid populations (which include DETC, dermal T cells and dILC2), respectively. All images obtained were 300 × 300 μm or 400 × 400 μm in the X--Y direction with a pixel resolution of 500 × 500 pixels. Two or 4 μm spacing in the z-axis was used through the entire depth of the tissue (up to 300 μm from the epidermis). Incrementing power when imaging deeper into the skin was facilitated through the Imspector software. Images were counted manually using the 'multi-point' selection tools (ImageJ, US National Institutes of Health) to determine the density of GFP^+^/YFP^+^ cells. The expression of fluorescent reporter genes by flow cytometry was obtained from ear skin samples and used to adjust the density of epidermal and dermal leukocytes for all skin sites. All GFP^+^ cells in c-Kit-eGFP mice were mast cells ([Supplementary Figure 3c](#SD2){ref-type="supplementary-material"}; [@R4]), and all GFP^+^ cells in the epidermis in MacGreen mice were MHC-II^hi^CD326^+^ LC ([@R31]). The other reporter mice utilized in this study required adjustment to determine the actual density based on the fact that 64±4.4% of CD64^−^MHC-II^hi^ DC expressed YFP in CD11c-YFP mice, while 42±10.5% of CD64^+^ macrophages were GFP^+^ in DPE-GFP mice. In *Cxcr6*^+/gfp^ mice, GFP expression was observed in all CD3^hi^ DETC and 72±5.2% of dermal CD90^hi^CD3^int^ T cells. Leukocyte density was determined by: density of cell A = \[density GFP^+^ cells\] × \[percentage of GFP^+^ cells of cell type A\] ÷ \[percentage of cell type A that are GFP^+^\] (see also [Supplementary Table 1](#SD2){ref-type="supplementary-material"}). Data was normalized to per mm^2^ or per mm^3^.
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![Deep tissue imaging by multiphoton microscopy demonstrates that spatial distribution of dermal leukocytes differ not only in depth but also between sites\
(a) Intravital imaging of ear skin of *Cxcr6*^+/gfp^ and *Csf1r*-EGFP (MacGreen) mice at various depths showing GFP^+^ cells (green) in the deep dermis (arrowheads), extracellular matrix in the dermis (SHG signals, blue) and blood vessels (Evans blue, red). Cartilage is visualized through autofluorescence (asterisk) (representative images from *n* = 2 mice per strain). Scale bar 50 μm. (b) Calculated densities of dermal dendritic cells (DDC), mast cells (MC), T cells and macrophages (Mac) at different sites, stratified by distance from the dermo-epidermal junction (DEJ). *n* = 3 for all strains; 6--12 fields of view per site, with flow cytometric adjustment for fluorescence expression with at least 12 mice per strain.](nihms610179f1){#F1}

![Topographical variation in leukocyte density in the epidermis and dermis\
Comparison of leukocyte densities at various cutaneous sites, calculated using the combinatorial approach of MPM and flow cytometry. (a) Langerhans cells (LC) (b) dermal dendritic cells (DDC) (c) mast cells (MC) (d) dendritic epidermal T cells (DETC) (e) dermal T cells and (f) macrophages (Mac). (g) Density of epidermal and dermal leukocytes at various cutaneous sites and (h) proportion of indicated dermal leukocytes according to site. Data are mean ± S.E.M. (*n* = 3 for all strains, 6--12 fields of view per site, with flow cytometric adjustment for fluorescence expression with at least 12 mice per strain; one-way ANOVA with Tukey post-test). \**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, \*\*\*\**P* \< 0.0001, ns, not significant.](nihms610179f2){#F2}

![Quantification of group 2 innate lymphoid cells and αβ and γδ T cells in ear skin of young and aged mice\
(a) Representative (n \> 8 per age group) image of GFP^+^ cells (green) in young (8--12 weeks) and older ear dermis (\> 12 months) of *Cxcr6*^+/gfp^ mice with ECM in dermis (SHG signals, blue) and dotted lines to indicate hair follicles. (b) Density of indicated populations in *Cxcr6*^+/gfp^ mouse ear skin in mice 8--12 weeks old and greater than 12 months old. Results are pooled from three independent experiments (\> 8 mice per age group). Data are mean ± S.E.M. and represent averaged flow-adjusted densities from both ears of each mouse. \*\**P* \< 0.01, ns, not significant (unpaired *t* test). Scale bar 100 μm.](nihms610179f3){#F3}

![Customized automated cell to blood vessel distance analysis of a migratory and non-migratory dermal population\
(a) *Left*: Representative intravital multiphoton microscopy (MPM) images of c-Kit-eGFP and CD11c-YFP ear skin showing GFP^+^ mast cells (MC; top, green), YFP^+^ dermal dendritic cells (DDC; bottom, yellow), extracellular matrix (SHG signals, blue) and vasculature (Evans blue, red). *Middle*: Computer-assisted recognition of cells (spots, yellow or green) and vasculature (purple). *Right*: Calculations of distances from every cell to nearest blood vessels (path in black). (b) Cumulative distribution function (CDF) of nearest distances of MC and DDC to vasculature in c-Kit-eGFP and CD11c-YFP mice respectively (in μm). (c) Box-whisker plot of cell to blood vessel distance in indicated populations (outliers excluded). *n* = 3 mice; 27 fields of view per strain; \> 2000 cells examined; \*\*\*\**P* \< 0.0001 (Mann-Whitney *U* test). Scale bar 100 μm.](nihms610179f4){#F4}

![Site-specific differences in mast cell numbers quantified by multiphoton imaging and the passive cutaneous anaphylaxis functional assay\
(a) Histology from albino C57BL/6*-Tyr^c-2J^*/J ear or back skin stained with H&E and toluidine blue; multiphoton microscopy (MPM) of c-Kit-eGFP ear or back skin demonstrating GFP^+^ mast cells (green), extracellular matrix (SHG signals, blue) and hair follicles (dotted lines). (b) Ear and back skin of albino C57BL/6*-Tyr^c-2J^*/J or mast cell-deficient C57BL/6J-*Kit*^W-sh/W-sh^ mice treated with vehicle or IgE anti-DNP (*i.d*. injection site, dotted lines) and challenged 16 h later with *i.v*. DNP-HSA containing Evans blue dye. (c) Dye extravasation (weight adjusted) for indicated sites and strains quantified by absorption at 610 nm (One-way ANOVA with Dunnett's post-test). Data are mean ± S.D.; \**P* \< 0.05; \*\*\**P* \<0.001. Scale bars 100 μm. Data representative of (a) 3 mice per strain, (b,c) \> 3 mice per strain per site.](nihms610179f5){#F5}
